Edition:
United States

Genovis AB (GENOb.ST)

GENOb.ST on Stockholm Stock Exchange

3.67SEK
22 Sep 2017
Change (% chg)

0.03kr (+0.82%)
Prev Close
3.64kr
Open
3.64kr
Day's High
3.70kr
Day's Low
3.54kr
Volume
27,040
Avg. Vol
68,397
52-wk High
4.20kr
52-wk Low
2.12kr

Chart for

About

Genovis AB is a Sweden-based company engaged in the research and development, production and marketing of technologies and products for cellular research. The Company offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer,... (more)

Overall

Beta: 0.53
Market Cap(Mil.): kr221.28
Shares Outstanding(Mil.): 60.29
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.44 16.08
EPS (TTM): -- -- --
ROI: -- 13.78 14.60
ROE: -- 16.62 14.03

BRIEF-Genovis signs distribution deal for Chinese market ​

* SIGNS DISTRIBUTION DEAL WITH ‍BEIJING ZHONGYUAN LTD FOR THE CHINESE MARKET ​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 18 2017

BRIEF-Genovis April-June operating loss down at SEK 2 mln

* APRIL-JUNE NET REVENUE SEK 5.8 MILLION VERSUS SEK 4.6 MILLION YEAR AGO

Aug 28 2017

BRIEF-Genovis Q1 net sales up at SEK 4.8 million

* Q1 NET SALES SEK 4.8 MILLION VERSUS SEK 3.8 MILLION YEAR AGO

May 08 2017

BRIEF-Genovis carries out directed share issue with proceeds of SEK 11.5 mln

* GENOVIS CARRIES OUT DIRECTED SHARE ISSUE WITH PROCEEDS OF SEK 11.5 MILLION

Apr 10 2017

Earnings vs. Estimates